Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
This study estimates the prevalence of prescription opioid use (POU) in the United States (US) in 2019–2020, both in the general population and specifically among adults with pain.
To better understand the impact of the pandemic on medication for opioid use disorder (MOUD) services in the U.S.
This qualitative narrative synthesis sought to identify pathways connecting socioeconomic marginalization (SEM) and overdose for people who use drugs.
Unregulated drug markets lead to samples with unexpected and variable contents. A retrospective data analysis of Zurich's DCS was performed to determine the nature of these samples.
We conducted this study to understand the rural context and factors that affected access of TiOAT programs.
We conducted an environmental scan to provide an overview of current organizational practices and characteristics of withdrawal management services (WMS) in Canadian substance use treatment systems
We assessed the psychometrics of a novel COVID-19 response-related discrimination scale among PWID, and characterized associations between COVID-19 response-related discrimination, resilience to ad
A clinical trial of a new OAT, depot buprenorphine provided the opportunity to obtain health and correctional staff perspectives regarding this treatment prior to widespread roll-out.
This study sought to understand how adaptations in the complex system of OAT provision impacted and responded to risk environments of people receiving OAT during the COVID-19 pandemic.
This mixed method, exploratory study utilized data from a larger study comprised of formerly incarcerated men (n = 57) and their selected social support partners (n = 57) to identify
The present study explores the processes through which take-home iOAT doses improved clients’ quality of life and continuity of care in real-life settings.
Patients with opioid use disorder (OUD) frequently leave the hospital as patient directed discharges (PDDs) because of untreated withdrawal and pain.
This review provides an overview of recent literature on the nature of recently published digital interventions for young people in terms of technologies used, substances targeted, intended outcome
This study addresses a knowledge gap by describing facilitators and barriers to OAT engagement among federal correctional populations released into the community in Ontario, Canada.
The current study utilized the socio-ecological model (SEM) to examine the synergistic impact of individual, interpersonal, community, and organizational/policy-level factors on reintegration exper
This study aimed to assess the impact of direct-acting antiviral (DAA) treatment success on quality of life (QoL) for people who inject drugs (PWID).
To quantify the association between opioid agonist treatment (OAT) and overdose death by age group; test the hypothesis that across different age groups, opioid overdose mortality is lowest during
Substance use disorders (SUD) are prevalent among justice-involved youth (JIY) and are a robust predictor of re-offending. Only a fraction of JIY with substance use problems receive treatment.